Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-14-001922
Filing Date
2014-02-21
Accepted
2014-02-21 16:17:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 d1454912_13-g.htm SC 13G 193562
  Complete submission text file 0000919574-14-001922.txt   195017
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79091 | Film No.: 14633832
SIC: 2834 Pharmaceutical Preparations

Mailing Address 237 PARK AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 237 PARK AVENUE 9TH FLOOR NEW YORK NY 10017 212-231-4932
Armistice Capital Fund LP (Filed by) CIK: 0001554349 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G